GlassScriptPhysician profile
James V Pasquariello
NPI 1871715169
$4,420.65
in general payments reported to CMS, 2019-2025
26 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,546 · 2020: $95.95 · 2021: $600 · 2022: $691 · 2023: $494 · 2024: $482 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,487.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $789.23 | 2019 | |
| Integra Lifesciences Corporation | $605.70 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $479.82 | 2019-2021 | |
| Davol INC. | $364.35 | 2020-2025 | Phasix Mesh |
| Allergan, INC. | $341.36 | 2019-2022 | |
| Kerecis Limited | $329.99 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Ambu INC. | $269.63 | 2022-2023 | |
| Abbvie INC. | $251.21 | 2023-2025 | |
| Stryker Corporation | $149.87 | 2019 | |
| Novo Nordisk INC | $149.18 | 2021-2022 | |
| Innovation Technologies INC | $141.09 | 2021 | |
| Sanara Medtech INC. | $92.37 | 2024 | Celleraterx |
| Medtronic, INC. | $78.57 | 2024 | Endoflip |
| Becton, Dickinson and Company | $62.03 | 2022 | |
| Karl Storz Endoscopy-America | $52.63 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $43.87 | 2024 | Impella |
| Next Science LLC | $36.22 | 2019-2021 | |
| Tela Bio, INC. | $28.12 | 2021 | |
| Intra-Sana Laboratories | $26.87 | 2022 | |
| Conmed Corporation | $26.20 | 2025 | Airseal |
| Abbott Laboratories | $23.68 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.13 | 2023 | Lifevest |
| Solventum Corporation | $18.68 | 2024 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Kowa Pharmaceuticals America, INC. | $15.09 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $13.85 | 2019 | |
| Olympus America INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Pasquariello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.